Koguchi M, Suzuki Y, Tanaka S, Fukayama S, Ishihara R, Deguchi K, Oda S, Nakane Y, Fukumoto T
Section of Studies, Tokyo Clinical Research Center.
Jpn J Antibiot. 1996 Mar;49(3):289-300.
To examine the antimicrobial activity of clarithromycin (CAM) against strains clinically isolated from outpatients in 1994, minimum inhibitory concentrations (MICs) were determined for CAM and the control drugs. The results were as follows; 1. MIC50 and MIC90 of CAM were similar to those investigated in 1980's against many bacterial species. 2. CAM showed strong antimicrobial activities against beta-lactamase producing Moraxella subgenus Branhamella catarrhalis, Bordetella pertussis, Campylobacter jejuni subsp. jejuni and Peptostreptococcus spp. 3. It appears that resistance to MLs including CAM is increasing among Streptococcus pneumoniae.
为检测1994年从门诊患者临床分离菌株中克拉霉素(CAM)的抗菌活性,测定了CAM及对照药物的最低抑菌浓度(MIC)。结果如下:1. CAM的MIC50和MIC90与20世纪80年代针对多种细菌的研究结果相似。2. CAM对产β-内酰胺酶的卡他莫拉菌布兰汉姆菌属、百日咳博德特氏菌、空肠弯曲菌空肠亚种和消化链球菌属表现出较强的抗菌活性。3. 肺炎链球菌对包括CAM在内的大环内酯类抗生素的耐药性似乎在增加。